Q2 2025 Holdings
Filed 2025-08-11 | 19 holdings | $277.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences Ltd.(ROIV) | SHS | G76279101 | $140.6M | 12,480,000 | 50.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $36.1M | 358,800 | 13.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $16.0M | 29,000 | 5.8% |
| Eyepoint Pharmaceuticals, Inc.(EYPT) | COM NEW | 30233G209 | $12.7M | 1,352,837 | 4.6% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $12.7M | 1,020,000 | 4.6% |
| Ocular Therapeutix, Inc.(OCUL) | COM | 67576A100 | $7.6M | 817,699 | 2.7% |
| Cullinan Therapeutics, Inc.(CGEM) | COM | 230031106 | $6.5M | 868,897 | 2.4% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $6.1M | 140,000 | 2.2% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $5.8M | 113,462 | 2.1% |
| Scholar Rock Holding Corporation(SRRK) | COM | 80706P103 | $5.5M | 154,000 | 2.0% |
| Enliven Therapeutics, Inc.(ELVN) | COM | 29337E102 | $4.9M | 245,838 | 1.8% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $4.7M | 412,296 | 1.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $4.6M | 139,732 | 1.7% |
| Pharvaris N. V.(PHVS) | COM | N69605108 | $4.3M | 244,283 | 1.6% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $3.9M | 74,000 | 1.4% |
| Allogene Therapeutics, Inc.(ALLO) | COM | 019770106 | $3.0M | 2,635,000 | 1.1% |
| Geron Corp(GERN) | COM | 374163103 | $1.0M | 716,000 | 0.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $730.7K | 15,000 | 0.3% |
| Vyne Therapeutics Inc.(VYNE) | COM | 92941V308 | $523.1K | 317,033 | 0.2% |